11 Capital Partners LP Danaher Corp Transaction History

11 Capital Partners LP

$227 Million
Q2 2024

A detailed history of 11 Capital Partners LP transactions in Danaher Corp stock. As of the latest transaction made, 11 Capital Partners LP holds 20,039 shares of DHR stock, worth $5.41 Million. This represents 2.21% of its overall portfolio holdings.

Number of Shares

20,039

Previous 47,339 57.67%

Holding current value

$5.41 Million

Previous $11.8 Million 57.65%

% of portfolio

2.21%

Previous 4.29%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$235.51 - $267.98 $6.43 Million - $7.32 Million	-27,300 Reduced 57.67%	20,039 $5.01 Million
Q1 2024 May 15, 2024	BUY	$224.58 - $256.19 $923,248 - $1.05 Million	4,111 Added 9.51%	47,339 $11.8 Million
Q4 2023 Feb 13, 2024	BUY	$185.1 - $233.13 $8 Million - $10.1 Million	43,228 New	43,228 $10 Million
Q2 2022 Aug 15, 2022	SELL	$237.11 - $299.66 $12.2 Million - $15.4 Million	-51,536 Reduced 53.65%	44,527 $11.3 Million
Q1 2022 May 16, 2022	BUY	$257.27 - $315.76 $7.49 Million - $9.2 Million	29,132 Added 43.53%	96,063 $28.2 Million
Q4 2021 Feb 14, 2022	BUY	$292.08 - $329.01 $3.48 Million - $3.92 Million	11,900 Added 21.62%	66,931 $22 Million
Q3 2021 Nov 15, 2021	SELL	$272.21 - $332.43 $6.83 Million - $8.34 Million	-25,075 Reduced 31.3%	55,031 $16.8 Million
Q2 2021 Aug 16, 2021	BUY	$225.08 - $271.69 $4.55 Million - $5.49 Million	20,194 Added 33.71%	80,106 $21.5 Million
Q1 2021 May 17, 2021	SELL	$212.38 - $245.9 $912,596 - $1.06 Million	-4,297 Reduced 6.69%	59,912 $13.5 Million
Q4 2020 Feb 12, 2021	BUY	$212.5 - $245.46 $13.6 Million - $15.8 Million	64,209 New	64,209 $14.3 Million

Others Institutions Holding DHR

# of Institutions

2,394

Shares Held

563M

Call Options Held

3.94M

Put Options Held

4.1M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $197B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 11 Capital Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on 11 Capital Partners LP with notifications on news.

Account

11 Capital Partners LP Danaher Corp Transaction History